Identify the actual bremelanotide preparation
An abbreviated PT-141 listing does not establish equivalence to a labeled bremelanotide medicine. The vial and spray formats should not inherit each other's evidence or an approved product's indication.
Documentation to request
Request exact formulation, manufacturer and labeling, then compare the intended product with the regulatory record cited by the supplier.
Regulatory context: FDA: compounding, approval and quality standards. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.
Related guidance: Product-by-product review for hormone clinics. These references support a review, not a treatment recommendation or supply authorization.